Psychosocial Patterns and Prognosis in Patients With Heart Failure
PANIC
Prognostic Value of Negative Affectivity in Patients With Heart Failure
1 other identifier
observational
325
1 country
1
Brief Summary
This prospective observational study is designed to confirm the prognostic and economic impact of depression in ambulatory patients with systolic or diastolic heart failure, to explore the impact of other psychosocial patterns such as type D personality, anxiety disorders, locus of control, perceived social support, anger, hopelessness, and to evaluate potential pathophysiological and behavioral pathways.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2007
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2007
CompletedFirst Submitted
Initial submission to the registry
July 2, 2008
CompletedFirst Posted
Study publicly available on registry
July 3, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedOctober 23, 2014
October 1, 2014
5 years
July 2, 2008
October 22, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cardiovascular mortality
2 years
Secondary Outcomes (1)
total mortality, sudden death rate, non cardiovascular mortality, rate of hospitalization, of rehospitalization for heart failure, of hospitalization for cardiovascular and non cardiovascular reasons,total health care costs and nature of theses costs
2 years
Eligibility Criteria
heart failure patients
You may qualify if:
- age above 18,
- acute heart failure within the last 24 months
- stable cardiovascular condition for at least 2 weeks
- non hospitalized, non institutionalized patient,
- french speaking and reading,
You may not qualify if:
- curable cardiomyopathy, cardiomyopathies associated with systemic illnesses (Lupus...), neurodegenerative or pulmonary illnesses, or hypertrophic/restrictive cardiomyopathy
- unstable cardiovascular condition
- heart transplant and hemodialysis patient
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hopital Georges pompidou
Paris, 75015, France
Biospecimen
serum, urine.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
François LEDRU, MD PH
Assistance Publique - Hôpitaux de Paris
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 2, 2008
First Posted
July 3, 2008
Study Start
December 1, 2007
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
October 23, 2014
Record last verified: 2014-10